Already a member? Sign in
Category: Prescription Drugs
Symlin® is a brand name of pramlintide, an antidiabetic agent. It is an injectable medicine used to control blood sugar after meals in adults with type 2 and type 1 diabetes who take mealtime insulin.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Other | 1 | 0 | |||||
| improve post-prandial blood sugars | 1 | 0 | |||||
| help the body realize it is full by simulating Amylin | 1 | 0 | |||||
| Diabetes Type 1 | 1 | 0 |
See 1 patient currently taking Symlin
Mouse over the table for more information
| 20 daily | ||
|---|---|---|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 1 | ||
| Side effects too severe | 1 | ||
| Other | 1 |
Stopped Taking Symlin
A bar graph
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.